Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

Cited In for PubMed (Select 10757792)

2.

IL-13 desensitizes β2-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism.

Albano GD, Zhao J, Etling EB, Park SY, Hu H, Trudeau JB, Profita M, Wenzel SE.

J Allergy Clin Immunol. 2015 May;135(5):1144-1153.e9. doi: 10.1016/j.jaci.2015.02.006. Epub 2015 Mar 24.

PMID:
25819984
3.
4.

Phosphatidylethanolamine-binding protein is not involved in µ-opioid receptor-mediated regulation of extracellular signal-regulated kinase.

Bian JM, Wu N, Su RB, Li J.

Mol Med Rep. 2015 May;11(5):3368-74. doi: 10.3892/mmr.2015.3161. Epub 2015 Jan 8.

5.

Protein tyrosine phosphatase receptor type R is required for Purkinje cell responsiveness in cerebellar long-term depression.

Erkens M, Tanaka-Yamamoto K, Cheron G, Márquez-Ruiz J, Prigogine C, Schepens JT, Nadif Kasri N, Augustine GJ, Hendriks WJ.

Mol Brain. 2015 Jan 9;8(1):1. doi: 10.1186/s13041-014-0092-8.

6.

The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and α-tocopherol.

Chen Y, Lin PX, Hsieh CL, Peng CC, Peng RY.

PLoS One. 2014 Dec 31;9(12):e116534. doi: 10.1371/journal.pone.0116534. eCollection 2014.

7.

Proteomic analysis of rat cartilage: the identification of differentially expressed proteins in the early stages of osteoarthritis.

Parra-Torres NM, Cázares-Raga FE, Kouri JB.

Proteome Sci. 2014 Nov 18;12(1):55. doi: 10.1186/s12953-014-0055-0. eCollection 2014.

8.

Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma.

Hill B, De Melo J, Yan J, Kapoor A, He L, Cutz JC, Feng X, Bakhtyar N, Tang D.

Oncotarget. 2014 Sep 15;5(17):7406-19.

9.

A General Network Pharmacodynamic Model-Based Design Pipeline for Customized Cancer Therapy Applied to the VEGFR Pathway.

Zhang XY, Birtwistle MR, Gallo JM.

CPT Pharmacometrics Syst Pharmacol. 2014 Jan 15;3:e92. doi: 10.1038/psp.2013.65.

10.

Biomarkers and mechanisms associated with recurrent prostate cancer.

Sharma S, Watabe K.

Front Biosci (Landmark Ed). 2014 Jan 1;19:339-51. Review.

11.

cis-Acting elements and trans-acting factors in the transcriptional regulation of raf kinase inhibitory protein expression.

Zhang B, Wang O, Qin J, Liu S, Sun S, Liu H, Kuang J, Jiang G, Zhang W.

PLoS One. 2013 Dec 26;8(12):e83097. doi: 10.1371/journal.pone.0083097. eCollection 2013.

12.

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).

Karamitopoulou E, Zlobec I, Gloor B, Kondi-Pafiti A, Lugli A, Perren A.

J Transl Med. 2013 Dec 14;11:311. doi: 10.1186/1479-5876-11-311.

13.

Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

Al-Mulla F, Bitar MS, Thiery JP, Zea TT, Chatterjee D, Bennett L, Park S, Edwards J, Yeung KC.

Am J Cancer Res. 2013 Nov 1;3(5):446-64. eCollection 2013.

14.

Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity.

Treviño JG, Verma M, Singh S, Pillai S, Zhang D, Pernazza D, Sebti SM, Lawrence NJ, Centeno BA, Chellappan SP.

Mol Cancer Ther. 2013 Dec;12(12):2722-34. doi: 10.1158/1535-7163.MCT-12-0719. Epub 2013 Oct 9.

15.

RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome.

Wright KT, Vella AT.

J Immunol. 2013 Jul 15;191(2):708-16. doi: 10.4049/jimmunol.1203486. Epub 2013 Jun 12.

16.

RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.

Martinho O, Pinto F, Granja S, Miranda-Gonçalves V, Moreira MA, Ribeiro LF, di Loreto C, Rosner MR, Longatto-Filho A, Reis RM.

PLoS One. 2013;8(3):e59104. doi: 10.1371/journal.pone.0059104. Epub 2013 Mar 19.

17.

Reduction of Raf Kinase Inhibitor Protein Expression is Associated with Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer.

Yan H, Guoqiang L, Shengxi C, Zhenghao D, Lingjin H.

Open Respir Med J. 2012;6:135-8. doi: 10.2174/1874306401206010135. Epub 2012 Nov 30.

18.

Outcome of R-CHOP or CHOP regimen for germinal center and nongerminal center subtypes of diffuse large B-cell lymphoma of Chinese patients.

Huang Y, Ye S, Cao Y, Li Z, Huang J, Huang H, Cai M, Luo R, Lin T.

ScientificWorldJournal. 2012;2012:897178. doi: 10.1100/2012/897178. Epub 2012 Nov 4.

19.

Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.

Das SK, Bhutia SK, Sokhi UK, Azab B, Su ZZ, Boukerche H, Anwar T, Moen EL, Chatterjee D, Pellecchia M, Sarkar D, Fisher PB.

Cancer Res. 2012 Dec 1;72(23):6217-26. doi: 10.1158/0008-5472.CAN-12-0402. Epub 2012 Oct 11.

20.

Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Montalto G, Cervello M, Nicoletti F, Fagone P, Malaponte G, Mazzarino MC, Candido S, Libra M, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Cocco L, Evangelisti C, Chiarini F, Martelli AM.

Oncotarget. 2012 Sep;3(9):954-87. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk